Zero-order release of 5-fluorouracil from PCL-based films featuring trilayered structures for stent application

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 78, Issue 1, 2011, Pages 49-57

  Lei, Lei ^a   Liu, Xi ^a   Shen, Yuan Yuan ^a   Liu, Jie Ying ^b   Tang, Mu Fei ^a   Wang, Zhong Min ^a,c   Guo, Sheng Rong ^a   Cheng, Liang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Suzhou University   (China)

Author keywords

5 Fluorouracil (5 FU); Controlled drug delivery; Film; Poly( caprolactone) (PCL); Scanning electron microscopy (SEM)

Indexed keywords

FLUOROURACIL; MACROGOL; POLYCAPROLACTONE; POROGEN; UNCLASSIFIED DRUG;

ARTICLE; DIFFUSION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; MOLECULAR WEIGHT; SCANNING ELECTRON MICROSCOPY; STENOSIS; STENT; THICKNESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUOROURACIL; MICROSCOPY, ELECTRON, SCANNING; POLYESTERS; STENTS; X-RAY DIFFRACTION;

EID: 79953161705     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.01.003     Document Type: Article

References (25)

1. A. Kotsar, T. Isotalo, I. Uurto, J. Mikkonen, P. Martikainen, M. Talja, M. Kellomaki, J.P. Salenius, and T.L.J. Tammela Urethral in situ biocompatibility of new drug-eluting biodegradable stents: an experimental study in the rabbit BJU Int. 103 2009 1132 1135
2. A. Finkelstein, D. McClean, S. Kar, K. Takizawa, K. Varghese, N. Baek, K. Park, M.C. Fishbein, R. Makkar, F. Litvack, and N.L. Eigler Local drug delivery via a coronary stent with programmable release pharmacokinetics Circulation 107 2003 777 784 (Pubitemid 36222609)
3. Q. Guo, S. Guo, and Z. Wang A type of esophageal stent coating composed of one 5-fluorouracil-containing EVA layer and one drug-free protective layer: in vitro release, permeation and mechanical properties J. Control. Release 118 2007 318 324 (Pubitemid 46441551)
4. J. Ako, H.N. Bonneau, Y. Honda, and P.J. Fitzgerald Design criteria for the ideal drug-eluting Stent Am. J. Cardiol. 100 2007 3M 9M
5. T. Tsuji, H. Tamai, K. Igaki, E. Kyo, K. Kosuga, T. Hata, M. Okada, T. Nakamura, S. Fujita, S. Takeda, S. Motohara, and H. Uehata Biodegradable stents as a platform to drug loading Int. J. Cardiovasc. Intervent. 5 2003 13 16 (Pubitemid 36227310)
6. M. Zilberman, and R.C. Eberhart Drug-eluting bioresorbable stents for various applications Annu. Rev. Biomed. Eng. 8 2006 153 180 (Pubitemid 44314815)
7. M. Zilberman, K.D. Nelson, and R.C. Eberhart Mechanical properties and in vitro degradation of bioresorbable fibers and expandable fiber-based stents J. Biomed. Mater. Res. Part B 74 2005 792 799 (Pubitemid 41076951)
8. M. Zilberman, Y. Shifrovitch, M. Aviv, and M. Hershkovitz Structured drug-eluting bioresorbable films: microstructure and release profile J. Biomater. Appl. 23 2009 385 406
9. M.C. Chen, C.T. Liu, H.W. Tsai, W.Y. Lai, Y. Chang, and H.W. Sung Mechanical properties, drug eluting characteristics and in vivo performance of a genipin-crosslinked chitosan polymeric stent Biomaterials 30 2009 5560 5571
10. A. Mochizuki, T. Niikawa, I. Omura, and S. Yamashita Controlled release of argatroban from PLA film - effect of hydroxylesters as additives on enhancement of drug release J. Appl. Polym. Sci. 108 2008 3353 3360 (Pubitemid 351652998)
11. L.L. Lao, and S.S. Venkatraman Paclitaxel release from single and double-layered poly(DL-lactide-co-glycolide)/poly(L-lactide) film for biodegradable coronary stent application J. Biomed. Mater. Res. Part A 87A 2008 1 7
12. C. Li, L. Cheng, Y. Zhang, S. Guo, and W. Wu Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants Int. J. Pharm. 386 2010 23 29
13. J. Weidner Drug delivery Drug Discov. Today 7 2002 632
14. V.R. Sinha, K. Bansal, R. Kaushik, R. Kumria, and A. Trehan Poly-[epsilon]-caprolactone microspheres and nanospheres: an overview Int. J. Pharm. 278 2004 1 23
15. S.R. Jameela, N. Suma, and A. Jayakrishnan Protein release from poly(-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study J. Biomater. Sci. Polym. Ed. 8 1997 457 466 (Pubitemid 27196922)
16. L. Ozel, M.S. Ozel, A.B. Toros, M. Kara, K.S. Ozkan, G. Tellioglu, O. Krand, M. Koyuturk, and I. Berber Effect of early preoperative 5-fluorouracil on the integrity of colonic anastomoses in rats World J. Gastroenterol. 15 2009 4156 4162
17. C.M. Dolinsky, N.N. Mahmoud, R. Mick, W. Sun, R.W. Whittington, L.J. Solin, D.G. Haller, B.J. Giantonio, P.J. O'Dwyer, E.F. Rosato, R.D. Fry, and J.M. Metz Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer J. Surg. Oncol. 96 2007 207 212 (Pubitemid 350194618)
18. E. Leo, B. Ruozi, G. Tosi, and M.A. Vandelli PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated Int. J. Pharm. 323 2006 131 138 (Pubitemid 44397362)
19. M. Sairam, V.R. Babu, B.V.K. Naidu, and T.M. Aminabhavi Encapsulation efficiency and controlled release characteristics of crosslinked polyacrylamide particles Int. J. Pharm. 320 2006 131 136 (Pubitemid 44128718)
20. K.S.V.K. Rao, I. Chung, K.M. Reddy, and C.S. Ha PMMA-based microgels for controlled release of an anticancer drug J. Appl. Polym. Sci. 111 2009 845 853
21. L. Cheng, S.R. Guo, and W.P. Wu Characterization and in vitro release of praziquantel from poly(epsilon-caprolactone) implants Int. J. Pharm. 377 2009 112 119
22. P. Costa, J. Manuel, and S. Lobo Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 2001 123 133 (Pubitemid 32288781)
23. I.C. Liao, S. Chen, J.B. Liu, and K.W. Leong Sustained viral gene delivery through core-shell fibers J. Control. Release 139 2009 48 55
24. C.H. Lu, and W.J. Lin Permeation of protein from porous poly(-caprolactone) films J. Biomed. Mater. Res. 63 2002 220 225
25. D. Pankajakshan, L.P. Philipose, M. Palakkal, K. Krishnan, and L.K. Krishnan Development of a fibrin composite-coated poly(ϵ-caprolactone) scaffold for potential vascular tissue engineering applications J. Biomed. Mater. Res. Part B 87B 2008 570 579